Mark J. Karbarz

机构：Io Therapeutics (United States) · ORCID：0000-0002-1006-8880

发表论文 25 篇 · 总被引 1903 次 · h-index 20

代表论文

A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa (2013 · Nature Medicine · 被引 701)
MsbA Transporter-dependent Lipid A 1-Dephosphorylation on the Periplasmic Surface of the Inner Membrane (2004 · Journal of Biological Chemistry · 被引 128)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial Demonstrating Reversal Of Rivaroxaban-Induced Anticoagulation In Healthy Subjects By Andexanet Alfa (PRT064445), An Antidote For Fxa Inhibitors (2013 · Blood · 被引 115)
Periplasmic Cleavage and Modification of the 1-Phosphate Group of Helicobacter pylori Lipid A (2004 · Journal of Biological Chemistry · 被引 98)
Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase (2008 · Bioorganic & Medicinal Chemistry Letters · 被引 92)
Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfa (2017 · Blood Advances · 被引 76)